H.C. Wainwright Reaffirms Their Buy Rating on Arrowhead Pharmaceuticals (ARWR)
at www.tipranks.com (Tue, 7-Apr 10:25 AM)
Arrowhead Pharmaceuticals to Join S&P MidCap 400: What the Index Shift Means for ARWR
Market Chameleon (Thu, 5-Feb 8:40 AM)
